Heffeter, P., Atil, B., Kryeziu, K., Groza, D., Koellensperger, G., Körner, W., . . . Berger, W. (2013). The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo(). Elsevier Science Ltd.
Dyfyniad Arddull ChicagoHeffeter, Petra, et al. The Ruthenium Compound KP1339 Potentiates the Anticancer Activity of Sorafenib in Vitro and in Vivo(). Elsevier Science Ltd, 2013.
Dyfyniad MLAHeffeter, Petra, et al. The Ruthenium Compound KP1339 Potentiates the Anticancer Activity of Sorafenib in Vitro and in Vivo(). Elsevier Science Ltd, 2013.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.